Advisory Committees; Filing of Closed Meeting Reports, 13131 [2012-5208]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 43 / Monday, March 5, 2012 / Notices
Estimated Total Annual Burden
Hours: 6,292.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information may be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. Email address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection activity—
National Child Abuse and Neglect Data
System.
The Department specifically requests
comments on: (a) The proposed change
to the two data collection instruments—
the Child File and the Agency File; (b)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(c) the quality, utility, and clarity of the
information to be collected; (d) the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information; and (e) ways to minimize
the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology.
Robert Sargis,
Reports Clearance Officer.
Copies are available from
the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852, 301–827–
6860.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Teresa L. Hays, Advisory Committee
and Oversight Management Staff, Food
and Drug Administration, 10903 New
Hampshire Ave., Silver Spring, MD
20993, 301–796–8220.
Under
section 10(d) of the Federal Advisory
Committee Act (5 U.S.C. app.) and 21
CFR 14.60(d), FDA has filed with the
Library of Congress the annual reports
for the following FDA advisory
committees that held closed meetings
during the period October 1, 2010
through September 30, 2011:
SUPPLEMENTARY INFORMATION:
Center for Biologics Evaluation and
Research
Allergenic Products Advisory
Committee
Blood Products Advisory Committee
Cellular, Tissue and Gene Therapies
Advisory Committee
Vaccines and Related Biological
Products Advisory Committee
Center for Drug Evaluation and
Research
Cardiovascular and Renal Drugs
Advisory Committee
Gastrointestinal Drug Advisory
Committee
National Center for Toxicological
Research
[FR Doc. 2012–5251 Filed 3–2–12; 8:45 am]
Science Board to the National Center for
Toxicological Research
BILLING CODE 4184–01–P
Center for Tobacco Products
Tobacco Products Scientific Advisory
Committee
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Advisory Committees; Filing of Closed
Meeting Reports
AGENCY:
Food and Drug Administration,
HHS.
erowe on DSK2VPTVN1PROD with NOTICES
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that, as required by the Federal
Advisory Committee Act, the Agency
has filed with the Library of Congress
the annual reports of those FDA
advisory committees that held closed
meetings during fiscal year 2011.
SUMMARY:
VerDate Mar<15>2010
15:06 Mar 02, 2012
Jkt 226001
Annual reports are available for
public inspections between 9 a.m. and
4 p.m., Monday through Friday.
• The Library of Congress, Madison
Bldg., Newspaper and Current
Periodical Reading Room, 101
Independence Ave. SE., Rm. 133,
Washington, DC; and
• The Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
Dated: February 23, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–5208 Filed 3–2–12; 8:45 am]
BILLING CODE 4160–01–P
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
13131
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection: Comment
Request Post-Award Reporting
Requirements Including New Research
Performance Progress Report
Collection
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of the Director, National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: Public
Health Service (PHS) Post-award
Reporting Requirements. Type of
Information Collection Request:
Revision. This collection represents a
consolidation of post-award reporting
requirements under the PRA, and
includes the new Research Performance
Progress Report (RPPR). Need and Use
of Information Collection: The RPPR
will replace existing interim
performance reports used by all NIH,
Food and Drug Administration, Centers
for Disease Control and Prevention, and
Agency for Healthcare Research and
Quality (AHRQ) grantees. Interim
progress reports are required to continue
support of a PHS grant for each budget
year within a competitive segment. The
phased transition to the RPPR requires
the maintenance of dual reporting
processes for a period of time. Thus this
information collection is for the new use
of the RPPR, and continued use of the
PHS Non-competing Continuation
Progress Report (PHS 2590, currently
approved under 0925–0001), and the
NIH AHRQ Ruth L. Kirschstein National
Research Service Award (NRSA)
Individual Fellowship Progress Report
for Continuation Support (PHS 416–9,
currently approved under 0925–0002).
Only one interim progress report (RPPR
or PHS2590/416–9) will be utilized for
any given award. This collection also
includes other PHS post-award
reporting requirements: PHS 416–7
NRSA Termination Notice, PHS 2271
Statement of Appointment, 6031–1
NRSA Annual Payback Activities
Certification, (currently approved under
0925–0002, expiration 6/30/2012); and
HHS 568 Final Invention Statement and
Certification, Final Progress Report
instructions, and iEdison, and PHS 3734
Statement Relinquishing Interests and
Rights in a PHS Research Grant
SUMMARY:
E:\FR\FM\05MRN1.SGM
05MRN1
]]>Agencies
[Federal Register Volume 77, Number 43 (Monday, March 5, 2012)]
[Notices]
[Page 13131]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5208]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0001]
Advisory Committees; Filing of Closed Meeting Reports
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that, as
required by the Federal Advisory Committee Act, the Agency has filed
with the Library of Congress the annual reports of those FDA advisory
committees that held closed meetings during fiscal year 2011.
ADDRESSES: Copies are available from the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 301-827-6860.
FOR FURTHER INFORMATION CONTACT: Teresa L. Hays, Advisory Committee and
Oversight Management Staff, Food and Drug Administration, 10903 New
Hampshire Ave., Silver Spring, MD 20993, 301-796-8220.
SUPPLEMENTARY INFORMATION: Under section 10(d) of the Federal Advisory
Committee Act (5 U.S.C. app.) and 21 CFR 14.60(d), FDA has filed with
the Library of Congress the annual reports for the following FDA
advisory committees that held closed meetings during the period October
1, 2010 through September 30, 2011:
Center for Biologics Evaluation and Research
Allergenic Products Advisory Committee
Blood Products Advisory Committee
Cellular, Tissue and Gene Therapies Advisory Committee
Vaccines and Related Biological Products Advisory Committee
Center for Drug Evaluation and Research
Cardiovascular and Renal Drugs Advisory Committee
Gastrointestinal Drug Advisory Committee
National Center for Toxicological Research
Science Board to the National Center for Toxicological Research
Center for Tobacco Products
Tobacco Products Scientific Advisory Committee
Annual reports are available for public inspections between 9 a.m.
and 4 p.m., Monday through Friday.
The Library of Congress, Madison Bldg., Newspaper and
Current Periodical Reading Room, 101 Independence Ave. SE., Rm. 133,
Washington, DC; and
The Division of Dockets Management (HFA-305), Food and
Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Dated: February 23, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-5208 Filed 3-2-12; 8:45 am]
BILLING CODE 4160-01-P
